Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 146

1.

Foci of cyclin A2 interact with actin and RhoA in mitosis.

Loukil A, Izard F, Georgieva M, Mashayekhan S, Blanchard JM, Parmeggiani A, Peter M.

Sci Rep. 2016 Jun 9;6:27215. doi: 10.1038/srep27215.

2.

Cyclin A2: At the crossroads of cell cycle and cell invasion.

Loukil A, Cheung CT, Bendris N, Lemmers B, Peter M, Blanchard JM.

World J Biol Chem. 2015 Nov 26;6(4):346-50. doi: 10.4331/wjbc.v6.i4.346. Review.

3.

Cyclin A2 modulates EMT via β-catenin and phospholipase C pathways.

Cheung CT, Bendris N, Paul C, Hamieh A, Anouar Y, Hahne M, Blanchard JM, Lemmers B.

Carcinogenesis. 2015 Aug;36(8):914-24. doi: 10.1093/carcin/bgv069. Epub 2015 May 19.

PMID:
25993989
4.

Cell cycle, cytoskeleton dynamics and beyond: the many functions of cyclins and CDK inhibitors.

Bendris N, Lemmers B, Blanchard JM.

Cell Cycle. 2015;14(12):1786-98. doi: 10.1080/15384101.2014.998085. Review.

5.

Kizuna is a novel mitotic substrate for CDC25B phosphatase.

Thomas Y, Peter M, Mechali F, Blanchard JM, Coux O, Baldin V.

Cell Cycle. 2014;13(24):3867-77. doi: 10.4161/15384101.2014.972882.

6.

Cyclin A2, a novel regulator of EMT.

Bendris N, Cheung CT, Leong HS, Lewis JD, Chambers AF, Blanchard JM, Lemmers B.

Cell Mol Life Sci. 2014 Dec;71(24):4881-94. doi: 10.1007/s00018-014-1654-8. Epub 2014 May 31.

PMID:
24879294
7.

High-resolution live-cell imaging reveals novel cyclin A2 degradation foci involving autophagy.

Loukil A, Zonca M, Rebouissou C, Baldin V, Coux O, Biard-Piechaczyk M, Blanchard JM, Peter M.

J Cell Sci. 2014 May 15;127(Pt 10):2145-50. doi: 10.1242/jcs.139188. Epub 2014 Mar 14.

8.

Tissue-specific and SRSF1-dependent splicing of fibronectin, a matrix protein that controls host cell invasion.

Lopez-Mejia IC, De Toledo M, Della Seta F, Fafet P, Rebouissou C, Deleuze V, Blanchard JM, Jorgensen C, Tazi J, Vignais ML.

Mol Biol Cell. 2013 Oct;24(20):3164-76. doi: 10.1091/mbc.E13-03-0142. Epub 2013 Aug 21.

9.

To be or not to be a proliferation marker?

Blanchard JM.

Oncogene. 2014 Feb 20;33(8):954-5. doi: 10.1038/onc.2013.19. Epub 2013 Feb 11.

PMID:
23396366
10.

Cyclin A2: a genuine cell cycle regulator?

Bendris N, Loukil A, Cheung C, Arsic N, Rebouissou C, Hipskind R, Peter M, Lemmers B, Blanchard JM.

Biomol Concepts. 2012 Dec;3(6):535-43. doi: 10.1515/bmc-2012-0027.

PMID:
25436557
11.

Cyclin A2, Rho GTPases and EMT.

Bendris N, Arsic N, Lemmers B, Blanchard JM.

Small GTPases. 2012 Oct-Dec;3(4):225-8. doi: 10.4161/sgtp.20791. Epub 2012 Jun 27.

12.

Cyclin E drives human keratinocyte growth into differentiation.

Freije A, Ceballos L, Coisy M, Barnes L, Rosa M, De Diego E, Blanchard JM, Gandarillas A.

Oncogene. 2012 Dec 13;31(50):5180-92. doi: 10.1038/onc.2012.22. Epub 2012 Feb 20.

PMID:
22349815
13.

A novel function for Cyclin A2: control of cell invasion via RhoA signaling.

Arsic N, Bendris N, Peter M, Begon-Pescia C, Rebouissou C, Gadéa G, Bouquier N, Bibeau F, Lemmers B, Blanchard JM.

J Cell Biol. 2012 Jan 9;196(1):147-62. doi: 10.1083/jcb.201102085.

14.

Cyclin A2 mutagenesis analysis: a new insight into CDK activation and cellular localization requirements.

Bendris N, Lemmers B, Blanchard JM, Arsic N.

PLoS One. 2011;6(7):e22879. doi: 10.1371/journal.pone.0022879. Epub 2011 Jul 28.

15.

A novel mouse c-fos intronic promoter that responds to CREB and AP-1 is developmentally regulated in vivo.

Coulon V, Chebli K, Cavelier P, Blanchard JM.

PLoS One. 2010 Jun 21;5(6):e11235. doi: 10.1371/journal.pone.0011235.

16.

Role for Brm in cell growth control.

Coisy-Quivy M, Disson O, Roure V, Muchardt C, Blanchard JM, Dantonel JC.

Cancer Res. 2006 May 15;66(10):5069-76.

17.

Cell type-dependent control of NF-Y activity by TGF-beta.

Alabert C, Rogers L, Kahn L, Niellez S, Fafet P, Cerulis S, Blanchard JM, Hipskind RA, Vignais ML.

Oncogene. 2006 Jun 8;25(24):3387-96. Epub 2006 Jan 23.

PMID:
16434965
18.

Ecotoxicological risk assessment of hospital wastewater: a proposed framework for raw effluents discharging into urban sewer network.

Emmanuel E, Perrodin Y, Keck G, Blanchard JM, Vermande P.

J Hazard Mater. 2005 Jan 14;117(1):1-11.

PMID:
15621348
19.

Cyclin A repression in quiescent cells is associated with chromatin remodeling of its promoter and requires Brahma/SNF2alpha.

Coisy M, Roure V, Ribot M, Philips A, Muchardt C, Blanchard JM, Dantonel JC.

Mol Cell. 2004 Jul 2;15(1):43-56.

20.

Toxicological effects of disinfections using sodium hypochlorite on aquatic organisms and its contribution to AOX formation in hospital wastewater.

Emmanuel E, Keck G, Blanchard JM, Vermande P, Perrodin Y.

Environ Int. 2004 Sep;30(7):891-900.

PMID:
15196837
21.

Retroviral genomic RNAs are transported to the plasma membrane by endosomal vesicles.

Basyuk E, Galli T, Mougel M, Blanchard JM, Sitbon M, Bertrand E.

Dev Cell. 2003 Jul;5(1):161-74.

22.

[Oncogenes and mitotic regulators: a change in perspective of our view of neoplastic processes].

Blanchard JM.

Med Sci (Paris). 2003 Feb;19(2):187-99. Review. French.

23.

[Bladder tumor in young patients: a series of 26 cases. Comparison with a review of the literature].

Blanchard JM, Graziana JP, Bonnal JL, Biserte J, Mauroy B.

Prog Urol. 2003 Apr;13(2):227-33. Review. French.

PMID:
12765056
24.

The RasGAP-associated endoribonuclease G3BP assembles stress granules.

Tourrière H, Chebli K, Zekri L, Courselaud B, Blanchard JM, Bertrand E, Tazi J.

J Cell Biol. 2003 Mar 17;160(6):823-31.

25.

Single mRNA molecules demonstrate probabilistic movement in living mammalian cells.

Fusco D, Accornero N, Lavoie B, Shenoy SM, Blanchard JM, Singer RH, Bertrand E.

Curr Biol. 2003 Jan 21;13(2):161-167.

26.

Intra-nuclear RNA trafficking: insights from live cell imaging.

Boulon S, Basyuk E, Blanchard JM, Bertrand E, Verheggen C.

Biochimie. 2002 Aug;84(8):805-13. Review.

PMID:
12457567
27.

Oct-1 potentiates CREB-driven cyclin D1 promoter activation via a phospho-CREB- and CREB binding protein-independent mechanism.

Boulon S, Dantonel JC, Binet V, Vié A, Blanchard JM, Hipskind RA, Philips A.

Mol Cell Biol. 2002 Nov;22(22):7769-79.

28.

Mammalian and yeast U3 snoRNPs are matured in specific and related nuclear compartments.

Verheggen C, Lafontaine DL, Samarsky D, Mouaikel J, Blanchard JM, Bordonné R, Bertrand E.

EMBO J. 2002 Jun 3;21(11):2736-45.

29.

[Molecular mechanisms of oncogenic transformation: what's new?].

Blanchard JM.

Bull Cancer. 2002 Jan;89(1):9-16. Review. French.

30.

Box C/D small nucleolar RNA trafficking involves small nucleolar RNP proteins, nucleolar factors and a novel nuclear domain.

Verheggen C, Mouaikel J, Thiry M, Blanchard JM, Tollervey D, Bordonné R, Lafontaine DL, Bertrand E.

EMBO J. 2001 Oct 1;20(19):5480-90.

31.

Terminal minihelix, a novel RNA motif that directs polymerase III transcripts to the cell cytoplasm. Terminal minihelix and RNA export.

Gwizdek C, Bertrand E, Dargemont C, Lefebvre JC, Blanchard JM, Singer RH, Doglio A.

J Biol Chem. 2001 Jul 13;276(28):25910-8. Epub 2001 May 7.

32.

Cyclin A is a mediator of p120E4F-dependent cell cycle arrest in G1.

Fajas L, Paul C, Vié A, Estrach S, Medema R, Blanchard JM, Sardet C, Vignais ML.

Mol Cell Biol. 2001 Apr;21(8):2956-66.

33.

mRNA localization by a 145-nucleotide region of the c-fos 3'--untranslated region. Links to translation but not stability.

Dalgleish G, Veyrune JL, Blanchard JM, Hesketh J.

J Biol Chem. 2001 Apr 27;276(17):13593-9. Epub 2001 Jan 3.

34.
35.

Switch from p53 to MDM2 as differentiating human keratinocytes lose their proliferative potential and increase in cellular size.

Dazard JE, Piette J, Basset-Seguin N, Blanchard JM, Gandarillas A.

Oncogene. 2000 Aug 3;19(33):3693-705.

36.
37.

Organ donor or graft pretreatment to prolong allograft survival: lessons learned in the murine model.

Pollak R, Blanchard JM.

Transplantation. 2000 Jun 15;69(11):2432-9.

PMID:
10868654
38.

Small GTPases, adhesion, cell cycle control and proliferation.

Blanchard JM.

Pathol Biol (Paris). 2000 Apr;48(3):318-27. Review.

PMID:
10858964
39.

Use of an alloreactive lymphocyte vaccine to prolong rat cardiac allograft survival.

Shallat J, Blanchard JM, Ward MG, Pollak R.

Transplant Proc. 2000 May;32(3):657-9. No abstract available.

PMID:
10812155
40.

Differential effect of Rac and Cdc42 on p38 kinase activity and cell cycle progression of nonadherent primary mouse fibroblasts.

Philips A, Roux P, Coulon V, Bellanger JM, Vié A, Vignais ML, Blanchard JM.

J Biol Chem. 2000 Feb 25;275(8):5911-7.

41.

CHF: a novel factor binding to cyclin A CHR corepressor element.

Philips A, Chambeyron S, Lamb N, Vié A, Blanchard JM.

Oncogene. 1999 Nov 4;18(46):6222-32.

42.

Localisation of a reporter transcript by the c-myc 3'-UTR is linked to translation.

Dalgleish GD, Veyrune JL, Accornero N, Blanchard JM, Hesketh JE.

Nucleic Acids Res. 1999 Nov 15;27(22):4363-8.

43.

A novel calcium signaling pathway targets the c-fos intragenic transcriptional pausing site.

Coulon V, Veyrune JL, Tourkine N, Vié A, Hipskind RA, Blanchard JM.

J Biol Chem. 1999 Oct 22;274(43):30439-46.

44.

Cyclin A is a functional target of retinoblastoma tumor suppressor protein-mediated cell cycle arrest.

Knudsen KE, Fribourg AF, Strobeck MW, Blanchard JM, Knudsen ES.

J Biol Chem. 1999 Sep 24;274(39):27632-41.

45.

Anchorage-dependent expression of cyclin A in primary cells requires a negative DNA regulatory element and a functional Rb.

Philips A, Huet X, Plet A, Rech J, Vié A, Blanchard JM.

Oncogene. 1999 Mar 11;18(10):1819-25.

46.

[Bright note on the molecular mechanisms of oncogenic transformation].

Blanchard JM.

Bull Cancer. 1999 Jan;86(1):9-14. Review. French. No abstract available.

47.

[Cyclin A: a good markers for the study of cell cycle control and tumor progression?].

Philips A, Huet X, Plet A, Rech J, Vignais ML, Vié A, Blanchard JM.

C R Seances Soc Biol Fil. 1998;192(2):223-30. Review. French.

PMID:
9759365
49.

How should Wellington and her colleagues react to the potential formation of a union?

Schurman S, Masters MF, Atkin RS, Blanchard JM, Feil F.

Harv Bus Rev. 1998 May-Jun;76(3):30-1, 34, 36-8. No abstract available.

PMID:
10179652
50.

The retinoblastoma protein is essential for cyclin A repression in quiescent cells.

Philips A, Huet X, Plet A, Le Cam L, Vié A, Blanchard JM.

Oncogene. 1998 Mar;16(11):1373-81.

Supplemental Content

Loading ...
Support Center